Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134829) titled 'Clinical Study on Early Intervention for Immune Checkpoint Inhibitor-Related Cardiac Injury in Malignant Tumors' on Oct. 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Hefei First People's Hospital
Condition:
Solid tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-26
Target Sample Size: Methylprednisolone group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344512
Disclaimer: Curated by HT Syndication....